Please assess the completion status of the following clinical trial:

Trial Title: Metoclopramide Pilot Trial

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Diagnosis of uncomplicated neonatal gastroschisis treated by primary fascial closure or delayed closure using a pre-formed silo (fascial closure or plastic closure)~2. Expectation of the treating physician that the patient will require intravenous therapy for at least 7 days post-enrolment~Exclusion Criteria:~1. Presence of other significant congenital malformation (ie life-threatening, requiring surgical intervention, or having an effect on intestinal motility)~2. Presence of intestinal atresia, intestinal necrosis or intestinal perforation (ie complicated gastroschisis)~3. Gestational age \<32 weeks~4. Birth weight \< 1500 gm~5. Received an investigational product within the past 30 days

- Gender: ALL
- Minimum Age: 33 Weeks
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- intravenous metoclopramide (Type: EXPERIMENTAL): the experimental arm will receive intravenous metoclopramide
- control arm (Type: PLACEBO_COMPARATOR): the control arm will receive placebo

Based on this trial design, predict the completion outcome and termination type (if applicable).